“PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY” (2020) Voprosy onkologii, 66(2), pp. 135–142. doi:10.37469/0507-3758-2020-66-2-135-142.